RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/35302851http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/35302851http://www.w3.org/2000/01/rdf-schema#comment"RAF kinases are highly conserved serine/threonine kinases, and among the three RAF isoforms (ARAF, BRAF, and CRAF), the pathophysiological relevance of ARAF is not well defined. Here, we show that patients with lung cancer exhibit low expression of ARAF, which is associated with lymph node metastasis and poor patient survival. We uncover that depletion of ARAF promotes anchorage-independent growth and metastasis through activation of AKT signaling in a subset of lung cancer cells. We identified that loss of ARAF was associated with an increase in ERBB3 expression in a kinase-independent manner. ARAF suppressed the promoter activity of ERBB3, and reconstitution of ARAF in ARAF-depleted cells led to the reversal of enhanced ERBB3-AKT signaling. Furthermore, ARAF inhibited neuregulin 1 (hNRG1)-mediated AKT activation through controlling ERBB3 expression via the transcription factor KLF5. Our results disclose a critical dual role for ARAF kinase in the negative regulation of ERBB3-AKT signaling, thereby suppressing tumor metastasis."xsd:string
http://purl.uniprot.org/citations/35302851http://purl.org/dc/terms/identifier"doi:10.1126/sciadv.abk1538"xsd:string
http://purl.uniprot.org/citations/35302851http://purl.uniprot.org/core/author"Klein M."xsd:string
http://purl.uniprot.org/citations/35302851http://purl.uniprot.org/core/author"Roth W."xsd:string
http://purl.uniprot.org/citations/35302851http://purl.uniprot.org/core/author"Rajalingam K."xsd:string
http://purl.uniprot.org/citations/35302851http://purl.uniprot.org/core/author"Marini F."xsd:string
http://purl.uniprot.org/citations/35302851http://purl.uniprot.org/core/author"Tegeder I."xsd:string
http://purl.uniprot.org/citations/35302851http://purl.uniprot.org/core/author"Werner U."xsd:string
http://purl.uniprot.org/citations/35302851http://purl.uniprot.org/core/author"Sadanandam A."xsd:string
http://purl.uniprot.org/citations/35302851http://purl.uniprot.org/core/author"Mooz J."xsd:string
http://purl.uniprot.org/citations/35302851http://purl.uniprot.org/core/author"Wilken-Schmitz A."xsd:string
http://purl.uniprot.org/citations/35302851http://purl.uniprot.org/core/author"Riegel K."xsd:string
http://purl.uniprot.org/citations/35302851http://purl.uniprot.org/core/author"Ps H."xsd:string
http://purl.uniprot.org/citations/35302851http://purl.uniprot.org/core/date"2022"xsd:gYear
http://purl.uniprot.org/citations/35302851http://purl.uniprot.org/core/name"Sci Adv"xsd:string
http://purl.uniprot.org/citations/35302851http://purl.uniprot.org/core/pages"eabk1538"xsd:string
http://purl.uniprot.org/citations/35302851http://purl.uniprot.org/core/title"ARAF suppresses ERBB3 expression and metastasis in a subset of lung cancers."xsd:string
http://purl.uniprot.org/citations/35302851http://purl.uniprot.org/core/volume"8"xsd:string
http://purl.uniprot.org/citations/35302851http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/35302851
http://purl.uniprot.org/citations/35302851http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/35302851
http://purl.uniprot.org/uniprot/#_A0A024R178-mappedCitation-35302851http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/35302851
http://purl.uniprot.org/uniprot/#_P10398-mappedCitation-35302851http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/35302851
http://purl.uniprot.org/uniprot/#_A0A0S2Z3F2-mappedCitation-35302851http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/35302851
http://purl.uniprot.org/uniprot/#_B4DGQ7-mappedCitation-35302851http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/35302851